Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Prianka Chilukuri"'
Autor:
Prianka Chilukuri, Mark A. Gromski, Cynthia S. Johnson, Duy Khanh P. Ceppa, Kenneth A. Kesler, Thomas J. Birdas, Karen M. Rieger, Hala Fatima, William R. Kessler, Douglas K. Rex, Mohammad Al-Haddad, John M. DeWitt
Publikováno v:
Endoscopy International Open, Vol 06, Iss 09, Pp E1085-E1092 (2018)
Background and aims The impact of the advent of an institutional endoscopic eradication therapy (EET) program on surgical practice for Barrett’s esophagus (BE)-associated high grade dysplasia (HGD) or suspected T1a esophageal adenocarcinoma (EAC) i
Externí odkaz:
https://doaj.org/article/9cc82f7be23f41a5a1ce8df1513b803e
Autor:
Hala Fatima, Prianka Chilukuri, Kenneth A. Kesler, John M. DeWitt, Mark A. Gromski, Mohammad A. Al-Haddad, Douglas K. Rex, William R. Kessler, Thomas J. Birdas, Karen M. Rieger, Cynthia S. Johnson, Duy Khanh P. Ceppa
Publikováno v:
Endoscopy International Open
Endoscopy International Open, Vol 06, Iss 09, Pp E1085-E1092 (2018)
Endoscopy International Open, Vol 06, Iss 09, Pp E1085-E1092 (2018)
Background and aims The impact of the advent of an institutional endoscopic eradication therapy (EET) program on surgical practice for Barrett’s esophagus (BE)-associated high grade dysplasia (HGD) or suspected T1a esophageal adenocarcinoma (EAC) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1bd620d85e2c7a601e4e6a74624686
http://europepmc.org/articles/PMC6133650
http://europepmc.org/articles/PMC6133650
Autor:
Monika Fischer, Arun Swaminath, Joseph Meserve, Khadija Chaudrey, Nitin Gupta, David Faleck, Corey A. Siegel, Eugenia Shmidt, Dana J. Lukin, William J. Sandborn, Bo Shen, Niels Vande Casteele, Matthew Bohm, Michelle Luo, Gursimran Kochhar, Jenna L. Koliani-Pace, David Hudesman, Siddharth Singh, Edward V. Loftus, Sunanda V. Kane, Keith Sultan, Shannon Chang, Robert Hirten, Parambir S. Dulai, Justin Hartke, Jean-Frederic Colombel, Karen Lasch, Morris Barocas, Brigid S. Boland, Sashidhar Sagi, Prianka Chilukuri, Bruce E. Sands
Publikováno v:
Inflammatory Bowel Diseases. 24:2461-2467
Background We quantified loss of response (LOR) to vedolizumab (VDZ) in clinical practice and assessed the effectiveness of VDZ dose intensification for managing LOR. Methods Retrospective review (May 2014–December 2016) of a prospectively maintain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7bf71d58fdc07d832d4e140e7a270f8
https://doi.org/10.1093/ibd/izy171
https://doi.org/10.1093/ibd/izy171
Publikováno v:
Missouri medicine. 115(3)
A complaint of dysphagia suggests difficulty in swallowing and is characterized based on the symptoms and location of pathology. Oropharyngeal dysphagia is typically due to difficulty initiating a swallow and is generally due to structural, anatomic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::84619041c44e6b6a46ead1f507ac1be9
https://pubmed.ncbi.nlm.nih.gov/30228723
https://pubmed.ncbi.nlm.nih.gov/30228723
Autor:
Karen Lasch, Diana Whitehead, Jenna L. Koliani-Pace, David Hudesman, Brian G. Feagan, Prianka Chilukuri, Gursimran Kochhar, Robert Hirten, Siddharth Singh, Malav P. Parikh, John T. Chang, Guangyong Zou, Leah Katta, Eugenia Shmidt, Justin Hartke, Sunanda V. Kane, Charlie Cao, Matthew Bohm, Farhad Peerani, Bruce E. Sands, Jean-Frederic Colombel, Edward V. Loftus, Keith Sultan, Dana J. Lukin, Vipul Jairath, Bo Shen, William J. Sandborn, Jesus Rivera-Nieves, Neeraj Narula, Adam Winters, Corey A. Siegel, Arun Swaminath, Joseph Meserve, Parambir S. Dulai, Khadija Chaudrey, Brigid S. Boland
Background & Aims As more treatment options for inflammatory bowel diseases become available, it is important to identify patients most likely to respond to different therapies. We created and validated a scoring system to identify patients with Croh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b86b5a69518157f3f7901d89bbed3f
https://europepmc.org/articles/PMC6419724/
https://europepmc.org/articles/PMC6419724/
BACKGROUND Concurrent autoimmune illnesses contribute to increased medical burden and reduced quality of life in patients with autoimmune hepatitis (AIH). The frequency of coexisting autoimmune conditions among North American patients with AIH and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f06ee19a85e1fd81cace122e927de5d2
https://doi.org/10.2196/preprints.9625
https://doi.org/10.2196/preprints.9625
Autor:
Dana J. Lukin, David Faleck, Adam Winters, Edward V. Loftus, Michelle Luo, Leah Katta, Robert Hirten, Sunanda V. Kane, Justin Hartke, Diana Whitehead, Khadija Chaudrey, Siddharth Singh, Monika Fischer, Keith Sultan, Brigid S. Boland, Corey A. Siegel, Arun Swaminath, Joseph Meserve, Bo Shen, Malav P. Parikh, Gursimran Kochhar, Bruce E. Sands, Parambir S. Dulai, Nitin Gupta, Farhad Peerani, Jenna L. Koliani-Pace, Morris Barocas, Eugenia Shmidt, William J. Sandborn, Neeraj Narula, Jean-Frederic Colombel, Shannon Chang, Karen Lasch, Prianka Chilukuri, Sashidhar Sagi, David Hudesman, Matthew Bohm
Publikováno v:
The American Journal of Gastroenterology
OBJECTIVES: We aimed to quantify the safety and effectiveness of vedolizumab (VDZ) when used for UC, and to identify predictors of response to treatment. METHODS: Retrospective review (May 2014 – December 2016) of VICTORY Consortium data. Adults wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4bde4727b59e3340292a58fd38e637d
https://pubmed.ncbi.nlm.nih.gov/30390030
https://pubmed.ncbi.nlm.nih.gov/30390030
Autor:
Megan Comerford, Rachel Fogel, James Robert Bailey, Prianka Chilukuri, Naga Chalasani, Craig Steven Lammert
BACKGROUND Conventional approaches to participant recruitment are often inadequate in rare disease investigation. Social networking sites such as Facebook may provide a vehicle to circumvent common research limitations and pitfalls. We report our pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ea8945055e49ce59d369602fe544d50
https://doi.org/10.2196/preprints.7683
https://doi.org/10.2196/preprints.7683
Autor:
Megan Comerford, Rachel Fogel, Prianka Chilukuri, Craig Lammert, Naga Chalasani, James Robert Bailey
Publikováno v:
Journal of Medical Internet Research
Background: Conventional approaches to participant recruitment are often inadequate in rare disease investigation. Social networking sites such as Facebook may provide a vehicle to circumvent common research limitations and pitfalls. We report our pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be566a399bf93849149610724aac112
https://pubmed.ncbi.nlm.nih.gov/29348111
https://pubmed.ncbi.nlm.nih.gov/29348111
Autor:
David Hudesman, Jean-Frederic Colombel, Adam Winters, Edward V. Loftus, Bo Shen, Robert Hirten, Monika Fischer, Brigid S. Boland, Matthew Bohm, Justin Hartke, David Faleck, Parambir S. Dulai, Sunanda V. Kane, Dana J. Lukin, Corey A. Siegel, Eugenia Shmidt, Keith Sultan, Satimai Aniwan, Shannon Chang, William J. Sandborn, Youran Gao, Gursimran Kochhar, Sashidhar Sagi, Bruce E. Sands, Prianka Chilukuri, Siddharth Singh, Shreva Chablaney, A Weiss, Preeti Shashi, Arun Swaminath, Joseph Meserve, Jenna L. Koliani-Pace, Nitin Gupta
Publikováno v:
Clin Gastroenterol Hepatol
Background & Aims There are few real-world data on the safety of vedolizumab for treatment of Crohn’s disease (CD) or ulcerative colitis (UC). We quantified rates and identified factors significantly associated with infectious and non-infectious ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9c275ea5f3d41f072fdb30a665d8ed
https://doi.org/10.1016/j.cgh.2018.09.035
https://doi.org/10.1016/j.cgh.2018.09.035